Jupiter Life Line Hospitals growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+18.9%+18.9%
EBITDA+15.8%+19.5%
Net Income+2.9%+39.8%
EPS (adj.)+0.6%+38.7%
Total Assets+25.1%+34.2%
Total Equity+13.9%+61.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JLHL₹260.10

Jupiter Life Line Hospitals Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSHCGMARKSANSMETROPOLISPARKHOSPSCORONAMcap ₹1,705 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+18.9+18.9
EBITDA+15.8+19.5
Net Income+2.9+39.8
EPS (adj.)+0.6+38.7
Total Assets+25.1+34.2
Total Equity+13.9+61.9
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.